Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: A peripheral stem cell transplant may be able to replace blood-forming cells that
were destroyed by chemotherapy or radiation therapy. Sometimes the transplanted cells from a
donor can make an immune response against the body's normal cells. Giving total-body
irradiation together with fludarabine, thiotepa, and antithymocyte globulin before transplant
may stop this from happening.
PURPOSE: This phase II trial is studying how well a donor stem cell transplant works in
treating patients with acute myeloid leukemia in remission.